{ "ticker": "UNH", "cik": "0000731766", "company": "UnitedHealth Group Incorporated", "business_type": "healthcare", "schema_template": "Diversified health care (health benefits plus health services): revenue split the way the company reports it (premiums, products, services, investment and other income); operating costs split into medical costs, operating costs, cost of products sold and depreciation and amortization; earnings from operations, net earnings and per-share figures; the medical care ratio the company reports (medical costs divided by premium revenue); and a balance sheet and cash flow on the company's own lines. Gross profit is not used because the company does not present one.", "reporting_currency": "USD", "converted_to_usd": false, "units": "actual dollars (not millions); share counts in actual shares (not millions); per-share amounts in dollars; ratios in percent. Figures keep the sign the statement prints: amounts shown in parentheses (interest expense, income tax provision, cash outflows) are negative.", "units_notes_seen": { "FY2025 10-K consolidated statements of operations": "(in millions, except per share data)", "FY2025 10-K consolidated balance sheets": "(in millions, except per share data)", "FY2025 10-K consolidated statements of cash flows": "(in millions)", "FY2025 10-K consolidated statements of changes in equity": "(in millions, except per share data)", "FY2025 10-K MD&A results summary (medical care ratio)": "(in millions, except percentages and per share data)", "Q2 2026 10-Q condensed consolidated statements of operations": "(in millions, except per share data)", "Q2 2026 10-Q condensed consolidated balance sheets": "(in millions, except per share data)", "Q2 2026 10-Q condensed consolidated statements of cash flows": "(in millions)", "Q2 2026 10-Q condensed consolidated statements of changes in equity": "Three months ended June 30, (in millions); Six months ended June 30, (in millions)", "Q2 2026 10-Q MD&A results summary (medical care ratio)": "(in millions, except percentages and per share data)" }, "adjustments": { "splits_applied": [], "adr_ratio": null, "fx": "none; the company reports in US dollars" }, "annual": [ { "label": "FY2025", "period_start": "2025-01-01", "period_end": "2025-12-31", "period_type": "fiscal year", "source_accession": "0000731766-26-000062", "fiscal_year": 2025, "income_statement": { "premiums": 352229000000, "products_revenue": 53380000000, "services_revenue": 38038000000, "investment_and_other_income": 3920000000, "total_revenues": 447567000000, "medical_costs": 313995000000, "operating_costs": 59592000000, "cost_of_products_sold": 50655000000, "depreciation_and_amortization": 4361000000, "total_operating_costs": 428603000000, "operating_income": 18964000000, "interest_expense": -4002000000, "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": -265000000, "earnings_before_income_taxes": 14697000000, "provision_for_income_taxes": -1890000000, "net_earnings": 12807000000, "earnings_attributable_to_noncontrolling_interests": -751000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 12056000000, "basic_eps": 13.28, "diluted_eps": 13.23, "basic_shares": 908000000, "diluted_shares": 911000000 }, "cash_flow": { "cash_flows_from_operating_activities": 19697000000, "capital_expenditures": -3622000000, "cash_paid_for_acquisitions_net_of_cash_assumed": -4509000000, "cash_flows_used_for_investing_activities": -8685000000, "common_share_repurchases": -5545000000, "cash_dividends_paid": -7916000000, "cash_flows_used_for_financing_activities": -11644000000, "free_cash_flow": 16075000000 }, "key_metrics": { "medical_care_ratio_percent": 89.1, "cash_dividends_paid_per_share": 8.73 }, "balance_sheet": { "cash_and_cash_equivalents": 24365000000, "short_term_investments": 3756000000, "accounts_receivable_net": 23018000000, "other_current_receivables_net": 29697000000, "prepaid_expenses_and_other_current_assets": 9746000000, "total_current_assets": 90582000000, "long_term_investments": 54251000000, "property_equipment_and_capitalized_software_net": 10762000000, "goodwill": 110499000000, "other_intangible_assets_net": 20474000000, "other_assets": 23013000000, "total_assets": 309581000000, "medical_costs_payable": 39337000000, "accounts_payable_and_accrued_liabilities": 38032000000, "short_term_borrowings_and_current_maturities_of_long_term_debt": 6069000000, "unearned_revenues": 3413000000, "other_current_liabilities": 28046000000, "total_current_liabilities": 114897000000, "long_term_debt_less_current_maturities": 72320000000, "deferred_income_taxes": 2421000000, "other_liabilities": 18245000000, "total_liabilities": 207883000000, "redeemable_noncontrolling_interests": 1608000000, "nonredeemable_noncontrolling_interests": 5980000000, "total_equity": 100090000000, "common_shares_outstanding": 906000000, "total_debt": 78389000000 } }, { "label": "FY2024", "period_start": "2024-01-01", "period_end": "2024-12-31", "period_type": "fiscal year", "source_accession": "0000731766-26-000062", "fiscal_year": 2024, "income_statement": { "premiums": 308810000000, "products_revenue": 50226000000, "services_revenue": 36040000000, "investment_and_other_income": 5202000000, "total_revenues": 400278000000, "medical_costs": 264185000000, "operating_costs": 53013000000, "cost_of_products_sold": 46694000000, "depreciation_and_amortization": 4099000000, "total_operating_costs": 367991000000, "operating_income": 32287000000, "interest_expense": -3906000000, "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": -8310000000, "earnings_before_income_taxes": 20071000000, "provision_for_income_taxes": -4829000000, "net_earnings": 15242000000, "earnings_attributable_to_noncontrolling_interests": -837000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 14405000000, "basic_eps": 15.64, "diluted_eps": 15.51, "basic_shares": 921000000, "diluted_shares": 929000000 }, "cash_flow": { "cash_flows_from_operating_activities": 24204000000, "capital_expenditures": -3499000000, "cash_paid_for_acquisitions_net_of_cash_assumed": -13408000000, "cash_flows_used_for_investing_activities": -20527000000, "common_share_repurchases": -9000000000, "cash_dividends_paid": -7533000000, "cash_flows_used_for_financing_activities": -3512000000, "free_cash_flow": 20705000000 }, "key_metrics": { "medical_care_ratio_percent": 85.5, "cash_dividends_paid_per_share": 8.18 }, "balance_sheet": { "cash_and_cash_equivalents": 25312000000, "short_term_investments": 3801000000, "accounts_receivable_net": 22365000000, "other_current_receivables_net": 26089000000, "prepaid_expenses_and_other_current_assets": 8212000000, "total_current_assets": 85779000000, "long_term_investments": 52354000000, "property_equipment_and_capitalized_software_net": 10553000000, "goodwill": 106734000000, "other_intangible_assets_net": 23268000000, "other_assets": 19590000000, "total_assets": 298278000000, "medical_costs_payable": 34224000000, "accounts_payable_and_accrued_liabilities": 34337000000, "short_term_borrowings_and_current_maturities_of_long_term_debt": 4545000000, "unearned_revenues": 3317000000, "other_current_liabilities": 27346000000, "total_current_liabilities": 103769000000, "long_term_debt_less_current_maturities": 72359000000, "deferred_income_taxes": 3620000000, "other_liabilities": 15939000000, "total_liabilities": 195687000000, "redeemable_noncontrolling_interests": 4323000000, "nonredeemable_noncontrolling_interests": 5610000000, "total_equity": 98268000000, "common_shares_outstanding": 915000000, "total_debt": 76904000000 } }, { "label": "FY2023", "period_start": "2023-01-01", "period_end": "2023-12-31", "period_type": "fiscal year", "source_accession": "0000731766-26-000062", "fiscal_year": 2023, "income_statement": { "premiums": 290827000000, "products_revenue": 42583000000, "services_revenue": 34123000000, "investment_and_other_income": 4089000000, "total_revenues": 371622000000, "medical_costs": 241894000000, "operating_costs": 54628000000, "cost_of_products_sold": 38770000000, "depreciation_and_amortization": 3972000000, "total_operating_costs": 339264000000, "operating_income": 32358000000, "interest_expense": -3246000000, "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": 0, "earnings_before_income_taxes": 29112000000, "provision_for_income_taxes": -5968000000, "net_earnings": 23144000000, "earnings_attributable_to_noncontrolling_interests": -763000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 22381000000, "basic_eps": 24.12, "diluted_eps": 23.86, "basic_shares": 928000000, "diluted_shares": 938000000 }, "cash_flow": { "cash_flows_from_operating_activities": 29068000000, "capital_expenditures": -3386000000, "cash_paid_for_acquisitions_net_of_cash_assumed": -10136000000, "cash_flows_used_for_investing_activities": -15574000000, "common_share_repurchases": -8000000000, "cash_dividends_paid": -6761000000, "cash_flows_used_for_financing_activities": -11529000000, "free_cash_flow": 25682000000 }, "key_metrics": { "medical_care_ratio_percent": 83.2, "cash_dividends_paid_per_share": 7.29 } } ], "quarterly": [ { "label": "Q2 FY2026", "period_start": "2026-04-01", "period_end": "2026-06-30", "period_type": "three months", "source_accession": "0000731766-26-000197", "fiscal_year": 2026, "fiscal_quarter": 2, "income_statement": { "premiums": 86956000000, "products_revenue": 13835000000, "services_revenue": 10018000000, "investment_and_other_income": 1223000000, "total_revenues": 112032000000, "medical_costs": 75358000000, "operating_costs": 14268000000, "cost_of_products_sold": 13375000000, "depreciation_and_amortization": 1040000000, "total_operating_costs": 104041000000, "operating_income": 7991000000, "interest_expense": -962000000, "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": -61000000, "earnings_before_income_taxes": 6968000000, "provision_for_income_taxes": -1298000000, "net_earnings": 5670000000, "earnings_attributable_to_noncontrolling_interests": -186000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 5484000000, "basic_eps": 6.06, "diluted_eps": 6.04, "basic_shares": 902000000, "diluted_shares": 906000000 }, "key_metrics": { "medical_care_ratio_percent": 86.7, "cash_dividends_paid_per_share": 2.32 }, "balance_sheet": { "cash_and_cash_equivalents": 28585000000, "short_term_investments": 2883000000, "accounts_receivable_net": 21573000000, "other_current_receivables_net": 24722000000, "prepaid_expenses_and_other_current_assets": 9097000000, "total_current_assets": 86860000000, "long_term_investments": 57716000000, "property_equipment_and_capitalized_software_net": 10762000000, "goodwill": 110645000000, "other_intangible_assets_net": 19749000000, "other_assets": 23995000000, "total_assets": 309727000000, "medical_costs_payable": 38930000000, "accounts_payable_and_accrued_liabilities": 39741000000, "short_term_borrowings_and_current_maturities_of_long_term_debt": 3827000000, "unearned_revenues": 2986000000, "other_current_liabilities": 26336000000, "total_current_liabilities": 111820000000, "long_term_debt_less_current_maturities": 69501000000, "deferred_income_taxes": 2722000000, "other_liabilities": 19735000000, "total_liabilities": 203778000000, "redeemable_noncontrolling_interests": 1436000000, "nonredeemable_noncontrolling_interests": 6066000000, "total_equity": 104513000000, "common_shares_outstanding": 905000000, "total_debt": 73328000000 } }, { "label": "Q2 FY2025", "period_start": "2025-04-01", "period_end": "2025-06-30", "period_type": "three months", "source_accession": "0000731766-26-000197", "fiscal_year": 2025, "fiscal_quarter": 2, "income_statement": { "premiums": 87905000000, "products_revenue": 13564000000, "services_revenue": 9039000000, "investment_and_other_income": 1108000000, "total_revenues": 111616000000, "medical_costs": 78585000000, "operating_costs": 13778000000, "cost_of_products_sold": 13019000000, "depreciation_and_amortization": 1084000000, "total_operating_costs": 106466000000, "operating_income": 5150000000, "interest_expense": -1027000000, "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": -41000000, "earnings_before_income_taxes": 4082000000, "provision_for_income_taxes": -510000000, "net_earnings": 3572000000, "earnings_attributable_to_noncontrolling_interests": -166000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 3406000000, "basic_eps": 3.76, "diluted_eps": 3.74, "basic_shares": 907000000, "diluted_shares": 910000000 }, "key_metrics": { "medical_care_ratio_percent": 89.4, "cash_dividends_paid_per_share": 2.21 } } ], "year_to_date": { "label": "Six months ended June 30, 2026", "period_start": "2026-01-01", "period_end": "2026-06-30", "period_type": "six months", "source_accession": "0000731766-26-000197", "income_statement": { "premiums": 174517000000, "products_revenue": 27085000000, "services_revenue": 19797000000, "investment_and_other_income": 2354000000, "total_revenues": 223753000000, "medical_costs": 148847000000, "operating_costs": 29658000000, "cost_of_products_sold": 26198000000, "depreciation_and_amortization": 2069000000, "total_operating_costs": 206772000000, "operating_income": 16981000000, "interest_expense": -1917000000, "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": -133000000, "earnings_before_income_taxes": 14931000000, "provision_for_income_taxes": -2780000000, "net_earnings": 12151000000, "earnings_attributable_to_noncontrolling_interests": -387000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 11764000000, "basic_eps": 12.98, "diluted_eps": 12.94, "basic_shares": 905000000, "diluted_shares": 908000000 }, "cash_flow": { "cash_flows_from_operating_activities": 19964000000, "capital_expenditures": -1562000000, "cash_paid_for_acquisitions_net_of_cash_assumed": -98000000, "cash_flows_used_for_investing_activities": -4245000000, "common_share_repurchases": -1646000000, "cash_dividends_paid": -4092000000, "cash_flows_used_for_financing_activities": -11615000000, "free_cash_flow": 18402000000 }, "key_metrics": { "medical_care_ratio_percent": 85.3, "cash_dividends_paid_per_share": 4.53 }, "prior_year_comparative": { "label": "Six months ended June 30, 2025", "period_start": "2025-01-01", "period_end": "2025-06-30", "period_type": "six months", "source_accession": "0000731766-26-000197", "income_statement": { "premiums": 174439000000, "products_revenue": 26600000000, "services_revenue": 18011000000, "investment_and_other_income": 2141000000, "total_revenues": 221191000000, "medical_costs": 151996000000, "operating_costs": 27372000000, "cost_of_products_sold": 25409000000, "depreciation_and_amortization": 2145000000, "total_operating_costs": 206922000000, "operating_income": 14269000000, "interest_expense": -2025000000, "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": -56000000, "earnings_before_income_taxes": 12188000000, "provision_for_income_taxes": -2142000000, "net_earnings": 10046000000, "earnings_attributable_to_noncontrolling_interests": -348000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 9698000000, "basic_eps": 10.66, "diluted_eps": 10.61, "basic_shares": 910000000, "diluted_shares": 914000000 }, "cash_flow": { "cash_flows_from_operating_activities": 12644000000, "capital_expenditures": -1784000000, "cash_paid_for_acquisitions_net_of_cash_assumed": -734000000, "cash_flows_used_for_investing_activities": -1516000000, "common_share_repurchases": -5545000000, "cash_dividends_paid": -3912000000, "cash_flows_used_for_financing_activities": -7848000000, "free_cash_flow": 10860000000 }, "key_metrics": { "medical_care_ratio_percent": 87.1, "cash_dividends_paid_per_share": 4.31 } } }, "trailing_twelve_months": { "label": "Twelve months ended June 30, 2026", "period_start": "2025-07-01", "period_end": "2026-06-30", "period_type": "trailing twelve months", "source_accession": "0000731766-26-000197", "source_accessions": [ "0000731766-26-000062", "0000731766-26-000197" ], "derivation": "Computed, not printed in either filing: full year 2025 from the FY2025 10-K (accession 0000731766-26-000062), plus the six months ended June 30, 2026, less the six months ended June 30, 2025, both from the Q2 2026 10-Q (accession 0000731766-26-000197).", "income_statement": { "premiums": 352307000000, "products_revenue": 53865000000, "services_revenue": 39824000000, "investment_and_other_income": 4133000000, "total_revenues": 450129000000, "medical_costs": 310846000000, "operating_costs": 61878000000, "cost_of_products_sold": 51444000000, "depreciation_and_amortization": 4285000000, "total_operating_costs": 428453000000, "operating_income": 21676000000, "earnings_before_income_taxes": 17440000000, "net_earnings": 14912000000, "net_earnings_attributable_to_unitedhealth_group_common_shareholders": 14122000000 }, "cash_flow": { "cash_flows_from_operating_activities": 27017000000, "capital_expenditures": -3400000000, "free_cash_flow": 23617000000 } }, "notes": [ "Sources: the three fiscal years (2023, 2024, 2025) and the December 31, 2025 and 2024 balance sheets come from the FY2025 Form 10-K (accession 0000731766-26-000062, filed March 2, 2026). The quarters ended June 30, 2026 and June 30, 2025, the six-month periods and the June 30, 2026 balance sheet come from the Q2 2026 Form 10-Q (accession 0000731766-26-000197, filed August 10, 2026).", "The 10-Q's December 31, 2025 balance sheet column matches the 10-K's balance sheet line for line.", "Line items follow the company's own statement captions. operating_income is the line the company labels \"Earnings from operations\". net_earnings_attributable_to_unitedhealth_group_common_shareholders is the figure earnings per share is based on; net_earnings includes the share belonging to noncontrolling interests.", "Signs follow the statements: interest expense, the provision for income taxes, the loss on sale of subsidiaries, earnings attributable to noncontrolling interests and every cash outflow are printed in parentheses and are stored as negative numbers.", "medical_care_ratio_percent is the medical care ratio as printed in the results summary of each filing's Management's Discussion and Analysis, which the company defines as medical costs divided by premium revenue.", "capital_expenditures is the cash flow line \"Purchases of property, equipment and capitalized software\".", "Computed figures, not printed in the filings: free_cash_flow is cash flows from operating activities less purchases of property, equipment and capitalized software; total_debt is \"Short-term borrowings and current maturities of long-term debt\" plus \"Long-term debt, less current maturities\". The trailing-twelve-month block is also computed, as described in that block.", "common_shares_outstanding is the share count on the closing balance rows of the statement of changes in equity, printed in millions. The 10-Q reports that forward share repurchase contracts covering 6.4 million shares bought by a counterparty were settled on July 1, 2026, after the June 30, 2026 balance sheet date.", "cash_dividends_paid_per_share is taken from the statement of changes in equity, which prints it in the caption of the cash dividends row (for example, \"Cash dividends paid on common shares ($ 2.32 per share)\" for the second quarter of 2026).", "Diluted earnings per share for the second quarter and first six months of 2026 ($6.04 and $12.94) are slightly below net earnings attributable to common shareholders divided by diluted shares. The 10-Q explains that the calculation of basic and diluted earnings per share includes an immaterial reduction to net earnings attributable to common shareholders for undistributed earnings attributable to shares held by the counterparty to its forward share repurchase contracts.", "The 10-Q presents its cash flow statement for the six months ended June 30 only, so the two quarters carry no cash flow block; the six-month cash flows are in year_to_date. The 10-Q prints no June 30, 2025 balance sheet, and the 10-K prints no December 31, 2023 balance sheet, so those periods carry none.", "No stock split, currency translation or depositary-share adjustment applies: the company reports in US dollars, its common stock trades directly on the NYSE, and it has had no stock split in the periods covered." ], "uncertainties": [ "Three-month cash flow figures for the second quarters of 2026 and 2025 are not given here. The 10-Q prints cash flows only for the six-month periods, and the first-quarter figures needed to separate out the second quarter are not in these two filings.", "Weighted-average share counts are printed rounded to the nearest million, so dividing net earnings by them reproduces the printed earnings per share only approximately." ], "headline": { "period": "Q2 FY2026", "period_end_words": "June 30, 2026", "metrics": [ { "label": "Revenue", "format": "usd", "value": 112032000000, "text": "$112.03 billion", "exact": "$112,032,000,000", "compact": "$112.03B", "abs": "$112.03 billion", "prior_value": 111616000000, "prior": "$111.62 billion", "priorabs": "$111.62 billion", "yoy": "up 0.4%", "source": { "array": "quarterly", "field": "income_statement.total_revenues", "index": 0, "period_label": "Q2 FY2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000731766-26-000197", "prior_index": 1, "prior_period_label": "Q2 FY2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000731766-26-000197", "gap_days": 365 } }, { "label": "Net earnings", "format": "usd", "value": 5484000000, "text": "$5.48 billion", "exact": "$5,484,000,000", "compact": "$5.48B", "abs": "$5.48 billion", "prior_value": 3406000000, "prior": "$3.41 billion", "priorabs": "$3.41 billion", "yoy": "up 61.0%", "source": { "array": "quarterly", "field": "income_statement.net_earnings_attributable_to_unitedhealth_group_common_shareholders", "index": 0, "period_label": "Q2 FY2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000731766-26-000197", "prior_index": 1, "prior_period_label": "Q2 FY2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000731766-26-000197", "gap_days": 365 } }, { "label": "Diluted EPS", "format": "eps", "value": 6.04, "text": "$6.04", "exact": "$6.04", "compact": "$6.04", "abs": "$6.04", "prior_value": 3.74, "prior": "$3.74", "priorabs": "$3.74", "yoy": "up 61.5%", "source": { "array": "quarterly", "field": "income_statement.diluted_eps", "index": 0, "period_label": "Q2 FY2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000731766-26-000197", "prior_index": 1, "prior_period_label": "Q2 FY2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000731766-26-000197", "gap_days": 365 } }, { "label": "Earnings from operations", "format": "usd", "value": 7991000000, "text": "$7.99 billion", "exact": "$7,991,000,000", "compact": "$7.99B", "abs": "$7.99 billion", "prior_value": 5150000000, "prior": "$5.15 billion", "priorabs": "$5.15 billion", "yoy": "up 55.2%", "source": { "array": "quarterly", "field": "income_statement.operating_income", "index": 0, "period_label": "Q2 FY2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000731766-26-000197", "prior_index": 1, "prior_period_label": "Q2 FY2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000731766-26-000197", "gap_days": 365 } }, { "label": "Medical care ratio", "format": "pct", "value": 86.7, "text": "86.7%", "exact": "86.7%", "compact": "86.7%", "abs": "86.7%", "prior_value": 89.4, "prior": "89.4%", "priorabs": "89.4%", "yoy": "down 2.7 points", "source": { "array": "quarterly", "field": "key_metrics.medical_care_ratio_percent", "index": 0, "period_label": "Q2 FY2026", "period_end": "2026-06-30", "period_start": "2026-04-01", "span_days": 90, "source_accession": "0000731766-26-000197", "prior_index": 1, "prior_period_label": "Q2 FY2025", "prior_period_end": "2025-06-30", "prior_period_start": "2025-04-01", "prior_span_days": 90, "prior_source_accession": "0000731766-26-000197", "gap_days": 365 } } ], "summary": "UnitedHealth Group reported net earnings attributable to common shareholders of $5.48 billion for Q2 FY2026, the quarter ended June 30, 2026, up 61.0% from a year earlier, or $6.04 per diluted share against $3.74. Total revenues were $112.03 billion, up 0.4%, while earnings from operations were $7.99 billion, up 55.2%. UnitedHealth Group's medical care ratio was 86.7%, down 2.7 points from a year earlier, which the company attributed to favorable development of prior-period medical cost reserves, affordability and medical cost management initiatives, and pricing.", "qa": [ { "q": "How much did UnitedHealth Group earn in Q2 FY2026?", "a": "UnitedHealth Group reported net earnings attributable to common shareholders of $5.48 billion for Q2 FY2026, the quarter ended June 30, 2026. That is up 61.0% from $3.41 billion in the same quarter a year earlier." }, { "q": "What was UnitedHealth Group's diluted EPS in Q2 FY2026?", "a": "UnitedHealth Group reported diluted earnings per share of $6.04 for Q2 FY2026, the quarter ended June 30, 2026, against $3.74 in the same quarter a year earlier, up 61.5%." }, { "q": "What was UnitedHealth Group's revenue in Q2 FY2026?", "a": "UnitedHealth Group's total revenues were $112.03 billion for Q2 FY2026, up 0.4% from $111.62 billion a year earlier. On that revenue, UnitedHealth Group's earnings from operations were $7.99 billion, up 55.2% from $5.15 billion." }, { "q": "What was UnitedHealth Group's medical care ratio in Q2 FY2026?", "a": "UnitedHealth Group's medical care ratio, its medical costs as a share of premium revenue, was 86.7% for Q2 FY2026, down 2.7 points from 89.4% a year earlier. The company attributed the lower ratio to favorable development of prior-period medical cost reserves, affordability and medical cost management initiatives, and pricing." } ] }, "company_details": { "Name": "Unitedhealth Group Inc", "Ticker": "UNH", "CIK": "0000731766", "Exchange": "NYSE", "State": "Minnesota", "Incorporation": "Delaware", "SIC": "6324", "Office": "Finance", "Industry": "Hospital & Medical Service Plans" }, "next_filing": { "predicted_date": "2026-10-27", "predicted_type": "10-Q" }, "fiscal_period": { "fiscal_year": 2026, "fiscal_period": "Q2", "tag": "FY26Q2", "period_end": "2026-06-30", "form": "10-Q", "accession": "0000731766-26-000197", "fiscal_year_end": "1231", "source": "facts" }, "source_filings": [ { "role": "annual", "current": false, "form": "10-K", "fiscal_year": 2025, "fiscal_period": "FY", "tag": "FY25", "period_end": "2025-12-31", "filed": "2026-03-02", "accession": "0000731766-26-000062", "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176626000062/0000731766-26-000062-index.htm", "source": "reported" }, { "role": "quarterly", "current": true, "form": "10-Q", "fiscal_year": 2026, "fiscal_period": "Q2", "tag": "FY26Q2", "period_end": "2026-06-30", "filed": "2026-08-10", "accession": "0000731766-26-000197", "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176626000197/0000731766-26-000197-index.htm", "source": "facts" } ], "figure_sources": { "about": "Where each figure in this file is printed in its SEC filing. This block mirrors the paths of the figures: figure_sources.annual[0].income_statement.net_income is the source of annual[0].income_statement.net_income. Each entry reads '#', and the link is documents[] + '#': it opens the filing at the line that prints that number. A figure with no entry is not printed in a tagged filing, either because it was calculated (margins, free cash flow, trailing twelve months, a quarter derived by subtraction) or because it comes from an untagged earnings release.", "documents": { "d1": "https://www.sec.gov/Archives/edgar/data/731766/000073176626000062/unh-20251231.htm", "d2": "https://www.sec.gov/Archives/edgar/data/731766/000073176626000197/unh-20260630.htm" }, "annual": [ { "period_end": "2025-12-31", "income_statement": { "premiums": "d1#f-146", "products_revenue": "d1#f-149", "services_revenue": "d1#f-152", "investment_and_other_income": "d1#f-155", "total_revenues": "d1#f-158", "operating_costs": "d1#f-164", "cost_of_products_sold": "d1#f-167", "depreciation_and_amortization": "d1#f-170", "total_operating_costs": "d1#f-173", "operating_income": "d1#f-176", "interest_expense": "d1#f-179", "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": "d1#f-182", "earnings_before_income_taxes": "d1#f-185", "provision_for_income_taxes": "d1#f-188", "net_earnings": "d1#f-191", "earnings_attributable_to_noncontrolling_interests": "d1#f-194", "net_earnings_attributable_to_unitedhealth_group_common_shareholders": "d1#f-197", "basic_eps": "d1#f-200", "diluted_eps": "d1#f-203", "basic_shares": "d1#f-206", "diluted_shares": "d1#f-212" }, "cash_flow": { "cash_flows_from_operating_activities": "d1#f-406", "capital_expenditures": "d1#f-1901", "cash_paid_for_acquisitions_net_of_cash_assumed": "d1#f-418", "cash_flows_used_for_investing_activities": "d1#f-442", "common_share_repurchases": "d1#f-445", "cash_dividends_paid": "d1#f-355", "cash_flows_used_for_financing_activities": "d1#f-472" }, "key_metrics": { "cash_dividends_paid_per_share": "d1#f-353" }, "balance_sheet": { "cash_and_cash_equivalents": "d1#f-58", "short_term_investments": "d1#f-60", "accounts_receivable_net": "d1#f-64", "other_current_receivables_net": "d1#f-68", "prepaid_expenses_and_other_current_assets": "d1#f-70", "total_current_assets": "d1#f-72", "long_term_investments": "d1#f-74", "property_equipment_and_capitalized_software_net": "d1#f-78", "goodwill": "d1#f-80", "other_intangible_assets_net": "d1#f-84", "other_assets": "d1#f-86", "total_assets": "d1#f-88", "medical_costs_payable": "d1#f-90", "accounts_payable_and_accrued_liabilities": "d1#f-92", "short_term_borrowings_and_current_maturities_of_long_term_debt": "d1#f-94", "unearned_revenues": "d1#f-96", "other_current_liabilities": "d1#f-98", "total_current_liabilities": "d1#f-100", "long_term_debt_less_current_maturities": "d1#f-102", "deferred_income_taxes": "d1#f-104", "other_liabilities": "d1#f-106", "total_liabilities": "d1#f-108", "redeemable_noncontrolling_interests": "d1#f-112", "nonredeemable_noncontrolling_interests": "d1#f-140", "total_equity": "d1#f-142", "common_shares_outstanding": "d1#f-128" } }, { "period_end": "2024-12-31", "income_statement": { "premiums": "d1#f-147", "products_revenue": "d1#f-150", "services_revenue": "d1#f-153", "investment_and_other_income": "d1#f-156", "total_revenues": "d1#f-159", "operating_costs": "d1#f-165", "cost_of_products_sold": "d1#f-168", "depreciation_and_amortization": "d1#f-171", "total_operating_costs": "d1#f-174", "operating_income": "d1#f-177", "interest_expense": "d1#f-180", "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": "d1#f-183", "earnings_before_income_taxes": "d1#f-186", "provision_for_income_taxes": "d1#f-189", "net_earnings": "d1#f-192", "earnings_attributable_to_noncontrolling_interests": "d1#f-195", "net_earnings_attributable_to_unitedhealth_group_common_shareholders": "d1#f-198", "basic_eps": "d1#f-201", "diluted_eps": "d1#f-204", "basic_shares": "d1#f-207", "diluted_shares": "d1#f-213" }, "cash_flow": { "cash_flows_from_operating_activities": "d1#f-407", "capital_expenditures": "d1#f-2021", "cash_paid_for_acquisitions_net_of_cash_assumed": "d1#f-419", "cash_flows_used_for_investing_activities": "d1#f-443", "common_share_repurchases": "d1#f-446", "cash_dividends_paid": "d1#f-321", "cash_flows_used_for_financing_activities": "d1#f-473" }, "key_metrics": { "cash_dividends_paid_per_share": "d1#f-319" }, "balance_sheet": { "cash_and_cash_equivalents": "d1#f-59", "short_term_investments": "d1#f-61", "accounts_receivable_net": "d1#f-65", "other_current_receivables_net": "d1#f-69", "prepaid_expenses_and_other_current_assets": "d1#f-71", "total_current_assets": "d1#f-73", "long_term_investments": "d1#f-75", "property_equipment_and_capitalized_software_net": "d1#f-79", "goodwill": "d1#f-81", "other_intangible_assets_net": "d1#f-85", "other_assets": "d1#f-87", "total_assets": "d1#f-89", "medical_costs_payable": "d1#f-91", "accounts_payable_and_accrued_liabilities": "d1#f-93", "short_term_borrowings_and_current_maturities_of_long_term_debt": "d1#f-95", "unearned_revenues": "d1#f-97", "other_current_liabilities": "d1#f-99", "total_current_liabilities": "d1#f-101", "long_term_debt_less_current_maturities": "d1#f-103", "deferred_income_taxes": "d1#f-105", "other_liabilities": "d1#f-107", "total_liabilities": "d1#f-109", "redeemable_noncontrolling_interests": "d1#f-113", "nonredeemable_noncontrolling_interests": "d1#f-141", "total_equity": "d1#f-143", "common_shares_outstanding": "d1#f-130" } }, { "period_end": "2023-12-31", "income_statement": { "premiums": "d1#f-148", "products_revenue": "d1#f-151", "services_revenue": "d1#f-154", "investment_and_other_income": "d1#f-157", "total_revenues": "d1#f-160", "operating_costs": "d1#f-166", "cost_of_products_sold": "d1#f-169", "depreciation_and_amortization": "d1#f-172", "total_operating_costs": "d1#f-175", "operating_income": "d1#f-178", "interest_expense": "d1#f-181", "earnings_before_income_taxes": "d1#f-187", "provision_for_income_taxes": "d1#f-190", "net_earnings": "d1#f-193", "earnings_attributable_to_noncontrolling_interests": "d1#f-196", "net_earnings_attributable_to_unitedhealth_group_common_shareholders": "d1#f-199", "basic_eps": "d1#f-202", "diluted_eps": "d1#f-205", "basic_shares": "d1#f-208", "diluted_shares": "d1#f-214" }, "cash_flow": { "cash_flows_from_operating_activities": "d1#f-408", "capital_expenditures": "d1#f-2133", "cash_paid_for_acquisitions_net_of_cash_assumed": "d1#f-420", "cash_flows_used_for_investing_activities": "d1#f-444", "common_share_repurchases": "d1#f-447", "cash_dividends_paid": "d1#f-287", "cash_flows_used_for_financing_activities": "d1#f-474" }, "key_metrics": { "cash_dividends_paid_per_share": "d1#f-285" } } ], "quarterly": [ { "period_end": "2026-06-30", "income_statement": { "premiums": "d2#f-114", "products_revenue": "d2#f-118", "services_revenue": "d2#f-122", "investment_and_other_income": "d2#f-126", "total_revenues": "d2#f-130", "medical_costs": "d2#f-134", "operating_costs": "d2#f-138", "cost_of_products_sold": "d2#f-142", "depreciation_and_amortization": "d2#f-146", "total_operating_costs": "d2#f-150", "operating_income": "d2#f-154", "interest_expense": "d2#f-158", "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": "d2#f-162", "earnings_before_income_taxes": "d2#f-166", "provision_for_income_taxes": "d2#f-170", "net_earnings": "d2#f-174", "earnings_attributable_to_noncontrolling_interests": "d2#f-178", "net_earnings_attributable_to_unitedhealth_group_common_shareholders": "d2#f-182", "basic_eps": "d2#f-186", "diluted_eps": "d2#f-190", "basic_shares": "d2#f-194", "diluted_shares": "d2#f-202" }, "key_metrics": { "cash_dividends_paid_per_share": "d2#f-291" }, "balance_sheet": { "cash_and_cash_equivalents": "d2#f-34", "short_term_investments": "d2#f-36", "accounts_receivable_net": "d2#f-38", "other_current_receivables_net": "d2#f-40", "prepaid_expenses_and_other_current_assets": "d2#f-42", "total_current_assets": "d2#f-44", "long_term_investments": "d2#f-46", "property_equipment_and_capitalized_software_net": "d2#f-48", "goodwill": "d2#f-50", "other_intangible_assets_net": "d2#f-52", "other_assets": "d2#f-54", "total_assets": "d2#f-56", "medical_costs_payable": "d2#f-58", "accounts_payable_and_accrued_liabilities": "d2#f-60", "short_term_borrowings_and_current_maturities_of_long_term_debt": "d2#f-62", "unearned_revenues": "d2#f-64", "other_current_liabilities": "d2#f-66", "total_current_liabilities": "d2#f-68", "long_term_debt_less_current_maturities": "d2#f-70", "deferred_income_taxes": "d2#f-72", "other_liabilities": "d2#f-74", "total_liabilities": "d2#f-76", "redeemable_noncontrolling_interests": "d2#f-80", "nonredeemable_noncontrolling_interests": "d2#f-108", "total_equity": "d2#f-110", "common_shares_outstanding": "d2#f-96", "total_debt": "d2#f-847" } }, { "period_end": "2025-06-30", "income_statement": { "premiums": "d2#f-115", "products_revenue": "d2#f-119", "services_revenue": "d2#f-123", "investment_and_other_income": "d2#f-127", "total_revenues": "d2#f-131", "medical_costs": "d2#f-135", "operating_costs": "d2#f-139", "cost_of_products_sold": "d2#f-143", "depreciation_and_amortization": "d2#f-147", "total_operating_costs": "d2#f-151", "operating_income": "d2#f-155", "interest_expense": "d2#f-159", "loss_on_sale_of_subsidiary_and_subsidiaries_held_for_sale": "d2#f-163", "earnings_before_income_taxes": "d2#f-167", "provision_for_income_taxes": "d2#f-171", "net_earnings": "d2#f-175", "earnings_attributable_to_noncontrolling_interests": "d2#f-179", "net_earnings_attributable_to_unitedhealth_group_common_shareholders": "d2#f-183", "basic_eps": "d2#f-187", "diluted_eps": "d2#f-191", "basic_shares": "d2#f-195", "diluted_shares": "d2#f-203" }, "key_metrics": { "cash_dividends_paid_per_share": "d2#f-333" } } ] } }